Mia's Feed
Medical News & Research

FDA Issues Updated Warning on Heart Risks Associated with Pfizer and Moderna COVID-19 Vaccines

FDA Issues Updated Warning on Heart Risks Associated with Pfizer and Moderna COVID-19 Vaccines

Share this article

The FDA has updated warnings for Pfizer and Moderna COVID-19 vaccines to highlight rare risks of myocarditis and pericarditis, especially in young males, based on new safety data.

2 min read

The U.S. Food and Drug Administration (FDA) has mandated that both Pfizer and Moderna update their COVID-19 vaccine warning labels to include information about rare instances of heart inflammation, particularly myocarditis and pericarditis. These side effects have been observed predominantly in male adolescents and young men aged 16 to 25, following reports from safety monitoring data and recent studies in 2023.

The new warnings specify that males in this age group are at the highest risk, with approximately 38 cases of myocarditis or pericarditis per million doses administered within this demographic. For individuals under 65 overall, the rate drops to about 8 cases per million doses. These conditions involve inflammation of the heart muscle and the lining surrounding the heart, respectively.

Most cases tend to occur shortly after vaccination and typically show improvement over time, often confirmed through heart MRI scans. However, the long-term implications of these findings remain uncertain, and studies are ongoing to assess possible long-term effects of myocarditis post-vaccination.

The FDA has given Pfizer and Moderna 30 days to respond to the new labeling requirements, although neither company has issued a public statement at this time. The decision follows a recent public disclosure just before a U.S. Senate hearing scrutinizing transparency concerns related to vaccine safety and adverse event reporting. FDA spokesperson Andrew Nixon emphasized the importance of transparency in vaccine safety, underscoring the commitment to informing the public about potential risks.

The Centers for Disease Control and Prevention (CDC) reassures that most myocarditis cases are manageable and resolve quickly, with ongoing research aimed at understanding long-term impacts. Despite these rare risks, vaccination remains a vital tool in combating COVID-19.

For further information, readers are encouraged to consult the CDC’s resources on COVID vaccines. This update enhances the transparency and safety communication surrounding mRNA COVID-19 vaccines.

Source: https://medicalxpress.com/news/2025-05-fda-heart-pfizer-moderna-covid.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Multilingual Brain and Stroke Recovery: How Speaking Multiple Languages Influences Aphasia Rehabilitation

Discover how speaking multiple languages influences stroke recovery and aphasia rehabilitation. Learn about brain networks, recovery patterns, and the importance of multilingual therapy in this insightful overview.

Preliminary Research Links Long Working Hours to Brain Structural Changes

Preliminary research suggests that working long hours—52 or more per week—may lead to structural changes in the brain, affecting emotional regulation and cognitive functions. The study highlights the need for occupational health policies to address overwork's neurological impacts.

Early Microbiome Composition in Infants Might Protect Against Childhood Viral Infections

Emerging research shows that the gut microbiome of newborns, especially within the first week, may help protect children against viral respiratory infections, paving the way for microbiome-based preventive strategies.